Doug Fisher

Doug joined Revelation Partners in 2020 as a Partner.

He is currently a board member of Gynesonics, Indi Molecular, Lycera, and Obalon Therapeutics.

Since 2009, Doug has been an Executive in Residence at InterWest Partners. Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments.

Doug received an A.B. in economics with honors and distinction, and a B.S. in biology with distinction, from Stanford, where he graduated Phi Beta Kappa. He has an M.D. from the University of Pennsylvania School of Medicine and an M.B.A. from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.